Amica Mutual Insurance Co. reduced its position in Morgan Stanley (NYSE:MS) by 51.1% in the fourth quarter, Holdings Channel reports. The institutional investor owned 56,321 shares of the financial services provider’s stock after selling 58,810 shares during the period. Amica Mutual Insurance Co.’s holdings in Morgan Stanley were worth $2,955,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other large investors have also recently added to or reduced their stakes in MS. Exane Derivatives boosted its holdings in shares of Morgan Stanley by 303.9% in the fourth quarter. Exane Derivatives now owns 1,979 shares of the financial services provider’s stock worth $104,000 after acquiring an additional 1,489 shares during the period. Invictus RG boosted its holdings in shares of Morgan Stanley by 307.5% in the third quarter. Invictus RG now owns 2,335 shares of the financial services provider’s stock worth $112,000 after acquiring an additional 1,762 shares during the period. Rational Advisors LLC bought a new position in shares of Morgan Stanley in the third quarter worth $116,000. Zions Bancorporation boosted its holdings in shares of Morgan Stanley by 176.1% in the third quarter. Zions Bancorporation now owns 2,463 shares of the financial services provider’s stock worth $119,000 after acquiring an additional 1,571 shares during the period. Finally, First Dallas Securities Inc. bought a new position in shares of Morgan Stanley in the fourth quarter worth $121,000. 86.32% of the stock is owned by institutional investors and hedge funds.
In other Morgan Stanley news, insider Keishi Hotsuki sold 25,000 shares of the firm’s stock in a transaction dated Tuesday, November 28th. The stock was sold at an average price of $50.00, for a total transaction of $1,250,000.00. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, insider Daniel A. Simkowitz sold 87,050 shares of the firm’s stock in a transaction dated Wednesday, February 14th. The shares were sold at an average price of $53.55, for a total value of $4,661,527.50. The disclosure for this sale can be found here. Insiders have sold 268,104 shares of company stock worth $14,524,785 in the last 90 days. Company insiders own 0.24% of the company’s stock.
Morgan Stanley (NYSE:MS) last released its quarterly earnings results on Thursday, January 18th. The financial services provider reported $0.84 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.77 by $0.07. Morgan Stanley had a return on equity of 10.03% and a net margin of 14.10%. The business had revenue of $9.50 billion for the quarter, compared to the consensus estimate of $9.25 billion. During the same quarter last year, the business posted $0.81 earnings per share. The company’s revenue for the quarter was up 5.3% on a year-over-year basis. equities research analysts forecast that Morgan Stanley will post 4.51 EPS for the current fiscal year.
The company also recently declared a quarterly dividend, which was paid on Thursday, February 15th. Shareholders of record on Wednesday, January 31st were given a dividend of $0.25 per share. The ex-dividend date was Tuesday, January 30th. This represents a $1.00 dividend on an annualized basis and a yield of 1.82%. Morgan Stanley’s payout ratio is 32.36%.
MS has been the subject of a number of analyst reports. Royal Bank of Canada reaffirmed a “buy” rating and issued a $60.00 price target on shares of Morgan Stanley in a report on Friday, January 19th. Wells Fargo & Co set a $55.00 price target on Morgan Stanley and gave the stock a “hold” rating in a report on Wednesday, December 20th. Zacks Investment Research raised Morgan Stanley from a “hold” rating to a “buy” rating and set a $59.00 price target for the company in a report on Wednesday, January 3rd. Keefe, Bruyette & Woods reaffirmed a “buy” rating and issued a $63.00 price target on shares of Morgan Stanley in a report on Friday, December 22nd. Finally, UBS Group raised Morgan Stanley to an “overweight” rating in a report on Wednesday, January 10th. One equities research analyst has rated the stock with a sell rating, seven have given a hold rating, sixteen have assigned a buy rating and one has assigned a strong buy rating to the company. The company has a consensus rating of “Buy” and a consensus target price of $54.07.
Morgan Stanley Company Profile
Morgan Stanley is a financial holding company. The Company’s segments include Institutional Securities, Wealth Management and Investment Management. The Company’s Institutional Securities business segment provides investment banking, sales and trading, and other services to corporations, governments, financial institutions and high-to-ultra high net worth clients.
Want to see what other hedge funds are holding MS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Morgan Stanley (NYSE:MS).
Receive News & Ratings for Morgan Stanley Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Morgan Stanley and related companies with MarketBeat.com's FREE daily email newsletter.